Category Resources

Awakening the Giant: The Next Frontier in mRNA Therapeutics

Awakening the Giant: The Next Frontier in mRNA Therapeutics

The remarkable success of messenger RNA-based vaccines during the COVID-19 pandemic has sparked widespread interest and enthusiasm around mRNA technology. But vaccines are just the beginning. Researchers and biotech innovators worldwide are rapidly uncovering the broader potential of mRNA to…

"The Evolving Needs of Therapeutic mRNA Developers" text over green background and DNA strand.

The Evolving Needs of Therapeutic mRNA Developers

Given the strides medical researchers and therapeutic developers were making, the possibility of commercializing mRNA therapeutics began looking bright about ten to fifteen years ago. However, one of the most pressing issues restricting researchers’ efforts was the lack of a…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—November 2024 Newsletter

mRNA for Antibody Manufacturing In collaboration, Charles River Lab and Vernal Biosciences released this scientific poster. Since its release, new advancements have been made and new data is available to share. Join the webinar on December 12 to dive into…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—October 2024 Newsletter

Nature Nanotechnology: Tissue-Specific mRNA Therapeutic Delivery Researchers have developed a combinatorial design of siloxane-incorporated LNPs to enhance tissue-specific mRNA therapeutic delivery. This article explains how this approach improves intracellular processing and stability of mRNA, showing promise for targeted treatments and…

Benefits of Partnering with a US-Based CDMO

The mRNA Monthly—September 2024 Newsletter

Speaking of Mol Bio Podcast In the latest episode (Season 2, Episode 8) of the Speaking of Mol Bio Podcast, hosts Steve Lewis and Dr. Christian Cobaugh, CEO of Vernal Biosciences, delve into the fascinating world of mRNA technology. The…